Caricamento...
Considerations in the development of generic disease therapies for multiple sclerosis
PURPOSE OF REVIEW: Medication prices are a major contributor to the high cost of care for multiple sclerosis (MS). The patents for some of the initial injectable therapies for relapsing MS recently expired, permitting development, regulatory approval, and marketing of generic alternatives with the p...
Salvato in:
| Pubblicato in: | Neurol Clin Pract |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Lippincott Williams & Wilkins
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4987120/ https://ncbi.nlm.nih.gov/pubmed/27574572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/CPJ.0000000000000267 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|